Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.trsl.2011.12.004PMID 22500508PMCID PMC3329218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome

  2012cited by this paper
• The Question Is, My Dear Watson, Why Did the Dog Not Bark?

  2011cited by this paper
• Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity—implications for autism

  2011cited by this paper
• Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes.

  2011cited by this paper
• Glyoxalase in diabetes, obesity and related disorders.

  2011cited by this paper
• Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy

  2011cited by this paper
• Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes

  2011cited by this paper
• Increased Accumulation of Skin Advanced Glycation End Products Is Associated with Microvascular Complications in Type 1 Diabetes

  2011cited by this paper
• The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort.

  2011cited by this paper
• Effects of metformin and pioglitazone on serum pentosidine levels in type 2 diabetes mellitus.

  2011cited by this paper
• Type 1 diabetes: etiology, immunology, and therapeutic strategies.

  2011cited by this paper
• Proteomic Analysis of Glycated Proteins from Streptozotocin-Induced Diabetic Rat Kidney

  2011cited by this paper
• Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration

  2011cited by this paper
• Glyoxalase in ageing.

  2011cited by this paper
• Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes

  2011cited by this paper
• Regulation of mitochondrial dynamics and neurodegenerative diseases.

  2011cited by this paper
• Reactive Metabolites and AGE/RAGE-Mediated Cellular Dysfunction Affect the Aging Process – A Mini-Review

  2010cited by this paper
• Inhibition of Methylglyoxal-Mediated Protein Modification in Glyoxalase I Overexpressing Mouse Lenses

  2010cited by this paper
• Glycotoxines, carbonyl stress and relevance to diabetes and its complications.

  2010cited by this paper
• AGEs and diabetic retinopathy.

  2010cited by this paper
• Methylglyoxal Alters the Function and Stability of Critical Components of the Protein Quality Control

  2010cited by this paper
• Diminished Superoxide Generation Is Associated With Respiratory Chain Dysfunction and Changes in the Mitochondrial Proteome of Sensory Neurons From Diabetic Rats

  2010cited by this paper
• Mitochondrial stress and the pathogenesis of diabetic neuropathy

  2010cited by this paper
• Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases

  2010cited by this paper
• Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

  2010cited by this paper
• DCCT and EDIC Studies in Type 1 Diabetes: Lessons for Diabetic Neuropathy Regarding Metabolic Memory and Natural History

  2010cited by this paper
• Advanced glycation endproducts and their pathogenic roles in neurological disorders

  2010cited by this paper
• Differences in Aggressive Behavior and DNA Copy Number Variants Between BALB/cJ and BALB/cByJ Substrains

  2010cited by this paper
• Mitochondrial Respiratory Chain Dysfunction in Dorsal Root Ganglia of Streptozotocin-Induced Diabetic Rats and Its Correction by Insulin Treatment

  2010cited by this paper
• Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats*

  2010cited by this paper
• Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

  2010influential reference
• Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging.

  2010cited by this paper
• Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments

  2009cited by this paper
• Mitochondrial dynamics and neurodegeneration

  2009cited by this paper
• A Common and Unstable Copy Number Variant Is Associated with Differences in Glo1 Expression and Anxiety-Like Behavior

  2009cited by this paper
• Hyperglycemia Impairs Proteasome Function by Methylglyoxal

  2009cited by this paper
• Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes.

  2009cited by this paper
• Development of Selective Axonopathy in Adult Sensory Neurons Isolated From Diabetic Rats

  2009cited by this paper
• C. elegans as Model for the Study of High Glucose– Mediated Life Span Reduction

  2009cited by this paper
• Advanced glycoxidation products and impaired diabetic wound healing

  2009cited by this paper
• MOLECULAR ENZYMOLOGY OF THE GLYOXALASE SYSTEM

  2008cited by this paper
• Reversal of Hyperglycemia‐Induced Angiogenesis Deficit of Human Endothelial Cells by Overexpression of Glyoxalase 1In Vitro

  2008cited by this paper
• Advanced glycation end products and diabetic foot disease

  2008influential reference
• Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress.

  2008cited by this paper
• The RAGE Pathway

  2008cited by this paper
• Diabetic neuropathy: mechanisms to management.

  2008cited by this paper
• Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?

  2008cited by this paper
• Mitochondria in neuroplasticity and neurological disorders.

  2008cited by this paper
• Modulation of Insulin Action by Advanced Glycation Endproducts: A New Player in the Field

  2008cited by this paper
• Neuronal Targeting in Diabetes Mellitus: A Story of Sensory Neurons and Motor Neurons

  2008cited by this paper
• Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy

  2008cited by this paper
• Early loss of peptidergic intraepidermal nerve fibers in an STZ‐induced mouse model of insensate diabetic neuropathy

  2008cited by this paper
• 糖尿病の3そろい(高血糖,腎機能および栄養)と進行糖化反応最終生成物(AGE):マルチ‐ヒット成分の証明?

  2008cited by this paper
• Receptor for Advanced Glycation End Products

  2008cited by this paper
• Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans

  2008cited by this paper
• PROTEIN AND NUCLEOTIDE DAMAGE BY GLYOXAL AND METHYLGLYOXAL IN PHYSIOLOGICAL SYSTEMS - ROLE IN AGEING AND DISEASE

  2008cited by this paper
• Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy

  2007cited by this paper
• Advanced glycation end products, diabetes and ageing

  2007influential reference
• Methylglyoxal and advanced glycation endproducts: new therapeutic horizons?

  2007cited by this paper
• Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress.

  2007cited by this paper
• Diabetic neuropathies.

  2007cited by this paper
• RAGE, diabetes, and the nervous system.

  2007cited by this paper
• Advanced glycation endproducts: what is their relevance to diabetic complications?

  2007cited by this paper
• Determination of glyoxal and methylglyoxal in the serum of diabetic patients by MEKC using stilbenediamine as derivatizing reagent

  2007cited by this paper
• Diabetic neuropathy—a review

  2007cited by this paper
• Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms.

  2007cited by this paper
• Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

  2006cited by this paper
• Heat‐shock protein 27 is a major methylglyoxal‐modified protein in endothelial cells

  2006cited by this paper
• Diagnostic tools for diabetic sensorimotor polyneuropathy.

  2006cited by this paper
• Methylglyoxal Impairs the Insulin Signaling Pathways Independently of the Formation of Intracellular Reactive Oxygen Species

  2006cited by this paper
• Glyoxalase I Is Critical for Human Retinal Capillary Pericyte Survival under Hyperglycemic Conditions*

  2006cited by this paper
• Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes

  2006cited by this paper
• Age-dependent changes of glyoxalase I expression in human brain.

  2006cited by this paper
• Global variation in copy number in the human genome

  2006cited by this paper
• A High-Resolution Map of Segmental DNA Copy Number Variation in the Mouse Genome

  2006cited by this paper
• Advanced glycation end products and the kidney.

  2005cited by this paper
• Advanced glycation endproducts--role in pathology of diabetic complications.

  2005cited by this paper
• The global burden of diabetic foot disease.

  2005cited by this paper
• Advanced glycation end products and the kidney

  2005cited by this paper
• Clinical implications of Nε‐(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes

  2005cited by this paper
• Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

  2005cited by this paper
• Distal symmetric polyneuropathy: A definition for clinical research

  2005cited by this paper
• Painful diabetic neuropathy

  2005cited by this paper
• Impaired peripheral nerve regeneration in diabetes mellitus

  2005cited by this paper
• Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation.

  2005cited by this paper
• Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes

  2005cited by this paper
• Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress.

  2005cited by this paper
• Diabetic Neuropathies: Classification, Clinical Features, and Pathophysiological Basis

  2005cited by this paper
• Sural nerve pathology in diabetic patients with minimal but progressive neuropathy

  2005cited by this paper
• Methylglyoxal Can Modify GAPDH Activity and Structure

  2005cited by this paper
• Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy

  2005cited by this paper
• Dicarbonyl Intermediates in the Maillard Reaction

  2005cited by this paper
• Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors

  2004cited by this paper
• Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.

  2004influential reference
• Glyoxalase I “null” allele in a new family: Identification by abnormal segregation pattern and quantitative assay

  2004cited by this paper
• Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy

  2004cited by this paper
• The evaluation of small fiber function-autonomic and quantitative sensory testing.

  2004cited by this paper
• The characterisation and functional analysis of the human glyoxalase-1 gene using methods of bioinformatics.

  2004cited by this paper
• Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

  2004cited by this paper
• α-Oxoaldehyde metabolism and diabetic complications

  2003cited by this paper

• Unravelling the pathophysiology of diabetic foot ulcer: insights into a complex wound healing process.

  2026cites this paper
• Inflammatory and neurotoxic risk of atorvastatin in diabetic peripheral neuropathy: TNF-centered evidence integrating network toxicology, scRNA-Seq, and cell validation.

  2026cites this paper
• Murraya koenigii Linn. modulate diabetic neuropathy via attenuation of mechanical hyperalgesia and allodynia in STZ-induced diabetic rats.

  2025cites this paper
• Therapeutic Interventions to Improve Static Balance in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

  2024cites this paper
• The analgesic effects of insulin and its disorders in streptozotocin‐induced short‐term diabetes

  2024cites this paper
• Vitamin B6 and diabetes and its role in counteracting advanced glycation end products.

  2024cites this paper
• Effective constituents and protective effect of Mudan granules against Schwann cell injury.

  2024cites this paper
• The Role of Serum Methylglyoxal and Glyoxalase 1 on Diabetic Peripheral Neuropathy

  2023cites this paper
• Cucurbita pepo seeds improve peripheral neuropathy in diabetic rats by modulating the inflammation and oxidative stress in rats

  2023cites this paper
• Diabetic peripheral neuropathy and their associations with overweight/obesity and impaired blood glucose among diabetic patients in Eastern Ethiopia: Institutional-based study

  2023cites this paper
• Diabetic Neuropathy: An Overview of Molecular Pathways and Protective Mechanisms of Phytobioactives.

  2023cites this paper
• Association between interleg systolic blood pressure difference and apparent peripheral neuropathy in US adults with diabetes: a cross-sectional study

  2023cites this paper
• Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions

  2023cites this paper
• Median nerve entrapment neuropathy before and early after sleeve gastrectomy in patients with diabetes mellitus; A prospective cross-sectional study.

  2022cites this paper
• Mechanisms behind diffuse idiopathic peripheral neuropathy in humans – a systematic review

  2022cites this paper
• Methylglyoxal in the Brain: From Glycolytic Metabolite to Signalling Molecule

  2022cites this paper
• New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective review

  2022cites this paper
• Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes

  2022influential citation
• Is metformin a possible treatment for diabetic neuropathy?

  2022cites this paper
• Effect of various exercise protocols on neuropathic pain in individuals with type 2 diabetes with peripheral neuropathy: A systematic review and meta-analysis.

  2022cites this paper
• Lutein attenuated methylglyoxal-induced oxidative damage and apoptosis in PC12 cells via the PI3K/Akt signaling pathway.

  2022cites this paper
• Glycation-induced age-related illnesses, antiglycation and drug delivery strategies.

  2022cites this paper
• Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus

  2022cites this paper
• Dicarbonyl Stress in Diabetic Vascular Disease

  2022cites this paper
• DDDT_A_356621 873..885

  2022cites this paper
• Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors

  2022cites this paper
• In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration

  2022cites this paper
• Selection of experimental models mimicking human pathophysiology for diabetic microvascular complications

  2022cites this paper
• Yeasts as Complementary Model Systems for the Study of the Pathological Repercussions of Enhanced Synphilin-1 Glycation and Oxidation

  2021cites this paper
• A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds

  2021cites this paper
• Differences in the skin microbiome and in suction blister fluids between individuals with diabetes mellitus type II and healthy individuals

  2021cites this paper
• Cnidoscolus aconitifolius: Nutritional, phytochemical composition and health benefits – A review

  2021cites this paper
• Treatment for diabetic peripheral neuropathy: What have we learned from animal models?

  2021cites this paper
• Applicability of High-Frequency Ultrasound to the Early Diagnosis of Diabetic Peripheral Neuropathy

  2021cites this paper
• Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres

  2021cites this paper
• A review on prevention of glycation of proteins: Potential therapeutic substances to mitigate the severity of diabetes complications.

  2021cites this paper
• Evaluation of Immunomodulatory Responses and Changed Wound Healing in Type 2 Diabetes—A Study Exploiting Dermal Fibroblasts from Diabetic and Non-Diabetic Human Donors

  2021cites this paper
• Peripheral Neuropathy Caused by Deficiency of Vitamin

  2021cites this paper
• The relationship between endogenous secretory RAGE and cardiac autonomic function in prediabetes

  2021cites this paper
• Receptor-like kinase OsASLRK regulates methylglyoxal response and content in rice

  2021cites this paper
• Electroacupuncture Alleviates Diabetic Peripheral Neuropathy by Regulating Glycolipid-Related GLO/AGEs/RAGE Axis

  2021cites this paper
• Polydatin protects Schwann cells from methylglyoxal induced cytotoxicity and promotes crushed sciatic nerves regeneration of diabetic rats

  2021cites this paper
• Glycosylation of CaV3.2 Channels Contributes to the Hyperalgesia in Peripheral Neuropathy of Type 1 Diabetes

  2020cites this paper
• Deciphering the Neuroprotective Role of Glucagon-like peptide-1 Agonists in Diabetic Neuropathy: Current Perspective and Future Directions.

  2020cites this paper
• Influence of the complex drug Cocarnit on the sciatic nerve in the development of diabetic polyneuropathy in rats

  2020cites this paper
• Glycation of heme-protein, “myoglobin” by 3-deoxyglucosone: Implications in immunogenicity

  2020cites this paper
• Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications and other age-related diseases.

  2020cites this paper
• The Experiences of People Living with Peripheral Neuropathy in Kuwait—A Process Map of the Patient Journey

  2019cites this paper
• The Akt/mTOR cascade mediates high glucose-induced reductions in BDNF via DNMT1 in Schwann cells in diabetic peripheral neuropathy.

  2019cites this paper
• Zebrafish is a central model to dissect the peripheral neuropathy

  2019cites this paper
• Disturbances of functional parameters of the visual system in conservatively treated and haemodialysed patients with non-diabetic chronic kidney disease

  2019cites this paper
• Opposing Effects of Neuropilin-1 and -2 on Sensory Nerve Regeneration in Wounded Corneas: Role of Sema3C in Ameliorating Diabetic Neurotrophic Keratopathy

  2019cites this paper
• Herbal Remedies: A Boon for Diabetic Neuropathy

  2019cites this paper
• Tanshinone IIa protects retinal endothelial cells against mitochondrial fission induced by methylglyoxal through glyoxalase 1.

  2019cites this paper
• Carnosine Prevents Different Structural Damages Induced by Methylglyoxal in Lens Crystallins

  2019cites this paper
• The role of Nav1.7 and methylglyoxal-mediated activation of TRPA1 in itch and hypoalgesia in a murine model of type 1 diabetes

  2019cites this paper
• Chronic diabetic peripheral neuropathic pain: psychometric properties of pain and physical function outcome measures

  2018cites this paper
• Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141-147 in Taiwanese with Alzheimer's disease.

  2018cites this paper
• Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy

  2018cites this paper
• The Impact of Type 2 Diabetes on Bone Fracture Healing

  2018cites this paper
• A comprehensive overview on osteoporosis and its risk factors

  2018cites this paper
• D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral neuropathy

  2018cites this paper
• Nerve conduction studies in patients with type 2 diabetes mellitus in Basrah

  2018cites this paper
• Analgesic Effects Of Synedrella Nodiflora (L) Gaertn Whole Plant Extract In Streptozotocin- Induced Diabetic Neuropathy In Rats.

  2018cites this paper
• Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.

  2017cites this paper
• The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.

  2017cites this paper
• Targeting Heat Shock Protein 70 to Improve Oxidative Stress and Mitochondrial Bioenergetics in Diabetic Sensory Neurons

  2017cites this paper
• Chromane isolated from leaves of Dillenia indica improves the neuronal dysfunction in STZ-induced diabetic neuropathy.

  2017cites this paper
• Étude de l'impact de la glycation sur la guérison des plaies cutanées

  2017influential citation
• Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes

  2017cites this paper
• Bacosine isolated from aerial parts of Bacopa monnieri improves the neuronal dysfunction in Streptozotocin-induced diabetic neuropathy

  2017cites this paper
• Methylglyoxal‐induced AMPK activation leads to autophagic degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells

  2017influential citation
• Probing Protein Glycation by Chromatography and Mass Spectrometry: Analysis of Glycation Adducts

  2017cites this paper
• Glucose-derived AGEs enhance human gastric cancer metastasis through RAGE/ERK/Sp1/MMP2 cascade

  2017cites this paper
• NATURAL COMPOUNDS THAT INHIBIT PROTEIN GLYCATION: A REVIEW FOR RECENT FINDINGS

  2017cites this paper
• Maillard Proteomics: Opening New Pages

  2017cites this paper
• Clinical measures of balance in people with type two diabetes: A systematic literature review.

  2017cites this paper
• Diabetes Mellitus and Diabetic Peripheral Neuropathy

  2017cites this paper
• The structural damages of lens crystallins induced by peroxynitrite and methylglyoxal, two causative players in diabetic complications and preventive role of lens antioxidant components.

  2017cites this paper
• Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments

  2016influential citation
• Profile of Congenital Surgical Anomalies in Neonates Admitted to Tertiary Care Neonatal Intensive Care Unit of Saurashtra Region

  2016cites this paper
• Evolving Insights into the Pathophysiology of Diabetic Neuropathy: Implications of Malfunctioning Glia and Discovery of Novel Therapeutic Targets.

  2016cites this paper
• Calcitriol prevents peripheral RSC96 Schwann neural cells from high glucose & methylglyoxal-induced injury through restoration of CBS/H2S expression.

  2016cites this paper
• Skin advanced glycation end products (AGEs), RAGE and Glyoxalase-I (GLO-I) are associated with diabetic neuropathy in patients with type 1 diabetes. -

  2016cites this paper
• Dendritic cell dysfunction and diabetic sensory neuropathy in the cornea.

  2016cites this paper
• STUDY OF MALONDIALDEHYDE AS OXIDATIVE STRESS AND SUPEROXIDE DISMUTASE AS ENZYMATIC ANTIOXIDANT IN TYPE II DIABETES MELLITUS PATIENTS WITH AND WITHOUT PERIPHERAL NEURITIS.

  2016cites this paper
• Studies on Glycated HSA assessment of optimal cut off value of Glycated HSA and its clinical relevance in diabetes and diabetes associated pathologies

  2016cites this paper
• Autofluorescence cutanée des produits de glycation avancée (AGE), mémoire métabolique et complications du diabète

  2016cites this paper
• Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy

  2016cites this paper
• Effect of proliferation of neurons and astrocytes is regulated by glyoxylase 1

  2016cites this paper
• Vitamin B12 and Holotranscobalamin Levels in Diabetic Peripheral Neuropathy Patients

  2016influential citation
• Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions

  2016cites this paper
• Quantitative sensory testing in type 1 diabetic patients with painful and painless diabetic neuropathy

  2016cites this paper
• Painful Diabetic Neuropathy: Prevention or Suppression?

  2016cites this paper
• RAGE and glyoxalase in kidney disease

  2016cites this paper
• The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition

  2015cites this paper
• Glycolaldehyde induces endoplasmic reticulum stress and apoptosis in Schwann cells

  2015cites this paper
• Oxidative, Nitrosative, and Chlorinative Stress: Biomarkers

  2015cites this paper
• Antiglycation and antioxidant properties of Momordica charantia

  2015cites this paper
• 2015 4th TERMIS World CongressBoston, MassachusettsSeptember 8–11, 2015

  2015cites this paper